G2 - Discovery based biotechnology company, specialising in the development of monoclonal antibody based pharmaceuticals
About G2 People Partnering News Contact
 
 

News

October 22, 2008
G2 & Novo Nordisk A/S announce the start of clinical trials (pdf, 100k)

February 8, 2006
G2 & Novo Nordisk A/S announce US$102m collaboration (pdf, 100k)

  
© G2 Therapies Pty Ltd 2008